Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 2Brain Neoplasms 2Non-squamous Non-small Cell Lung Cancer 1Neoplasms 1Adenocarcinoma 1

Interventions

Carboplatin 4Pemetrexed 3pembrolizumab 2Paclitaxel 2Cisplatin 2Bevacizumab 2icotinib 1Platinum 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Non-squamous Non-small Cell Lung Cancer × icotinib × Clear all
NCT03992885 2019-06-20

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Unknown
70 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡